Wenjun Yu

442 total citations
18 papers, 268 citations indexed

About

Wenjun Yu is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Wenjun Yu has authored 18 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Hematology. Recurrent topics in Wenjun Yu's work include Multiple Myeloma Research and Treatments (7 papers), Protein Degradation and Inhibitors (4 papers) and Peptidase Inhibition and Analysis (3 papers). Wenjun Yu is often cited by papers focused on Multiple Myeloma Research and Treatments (7 papers), Protein Degradation and Inhibitors (4 papers) and Peptidase Inhibition and Analysis (3 papers). Wenjun Yu collaborates with scholars based in China and Thailand. Wenjun Yu's co-authors include Mingna Zhao, Jiatao Lou, Qiaomei Guo, Chenzi Zhang, Lin Wang, Guohua Yang, Hang Zhao, Yingli Wu, Wenbin Xu and Lin Wang and has published in prestigious journals such as Scientific Reports, Small and BMC Cancer.

In The Last Decade

Wenjun Yu

16 papers receiving 266 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenjun Yu China 9 151 98 97 79 23 18 268
Hengyu Wu China 8 125 0.8× 79 0.8× 102 1.1× 41 0.5× 11 0.5× 17 212
Yijie Hao China 7 195 1.3× 152 1.6× 84 0.9× 24 0.3× 12 0.5× 10 266
Kenji M. Fujihara Australia 11 175 1.2× 61 0.6× 57 0.6× 71 0.9× 9 0.4× 15 253
Teresa Laguna Spain 9 106 0.7× 56 0.6× 41 0.4× 86 1.1× 12 0.5× 11 254
David T. Hoang United States 5 114 0.8× 64 0.7× 113 1.2× 76 1.0× 6 0.3× 7 256
Christine Brennan United States 4 152 1.0× 131 1.3× 63 0.6× 36 0.5× 8 0.3× 4 242
Diane Heiser United States 6 230 1.5× 96 1.0× 87 0.9× 80 1.0× 4 0.2× 9 322
Li Yuan China 8 139 0.9× 83 0.8× 82 0.8× 58 0.7× 4 0.2× 13 245
L. T. Busund Norway 7 149 1.0× 112 1.1× 47 0.5× 80 1.0× 7 0.3× 7 256
Jo Ballot Ireland 7 195 1.3× 67 0.7× 52 0.5× 99 1.3× 15 0.7× 9 290

Countries citing papers authored by Wenjun Yu

Since Specialization
Citations

This map shows the geographic impact of Wenjun Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenjun Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenjun Yu more than expected).

Fields of papers citing papers by Wenjun Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenjun Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenjun Yu. The network helps show where Wenjun Yu may publish in the future.

Co-authorship network of co-authors of Wenjun Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Wenjun Yu. A scholar is included among the top collaborators of Wenjun Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenjun Yu. Wenjun Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Wang, Dongjiao, Nian Zhou, Haimin Chen, et al.. (2025). Piwi-interacting RNA-823 promotes cell growth and chemoresistance by stimulating the TGF-β1-mediated AKT/ERK pathway in multiple myeloma. International Immunopharmacology. 166. 115405–115405.
2.
Yu, Wenjun, et al.. (2024). Association between dietary betaine intake and overweight or obesity. Scientific Reports. 14(1). 32031–32031. 3 indexed citations
3.
Yu, Yang, et al.. (2024). Mechanisms of endocrine resistance in hormone receptor-positive breast cancer. Frontiers in Oncology. 14. 1448687–1448687. 8 indexed citations
4.
Shi, Haotian, Wei Wei, Rong Peng, et al.. (2023). Continuous low-dose cyclophosphamide plus prednisone in the treatment of relapsed and refractory multiple myeloma with severe complications. Frontiers in Oncology. 13. 1185991–1185991. 1 indexed citations
5.
6.
7.
Meng, Fanyu, Wenjun Yu, Changqiang Chen, et al.. (2022). A Versatile Electrochemical Biosensor for the Detection of Circulating MicroRNA toward Non‐Small Cell Lung Cancer Diagnosis (Small 22/2022). Small. 18(22). 2 indexed citations
8.
Chen, Haimin, Haotian Shi, Nian Zhou, et al.. (2022). Evaluation of the Mayo Additive Staging System in patients with newly diagnosed multiple myeloma: A real‐world analysis. European Journal Of Haematology. 110(3). 229–235.
9.
Xia, Lei, Lin Wang, Wenjun Yu, et al.. (2020). High Expression of Long Noncoding RNA PCNA-AS1 Promotes Non-Small-Cell Lung Cancer Cell Proliferation and Oncogenic Activity via Upregulating CCND1. Journal of Cancer. 11(7). 1959–1967. 13 indexed citations
10.
Guo, Qiaomei, Lin Wang, Wenjun Yu, et al.. (2019). Detection of Plasma EGFR Mutations in NSCLC Patients with a Validated ddPCR Lung cfDNA Assay. Journal of Cancer. 10(18). 4341–4349. 23 indexed citations
11.
Tong, Jia, Qing Yu, Wenbin Xu, et al.. (2018). Montelukast enhances cytocidal effects of carfilzomib in multiple myeloma by inhibiting mTOR pathway. Cancer Biology & Therapy. 20(3). 381–390. 8 indexed citations
12.
Yu, Dongmei, et al.. (2018). [Prevalence and characteristics of overweight and obesity in Chinese children aged 0-5 years].. PubMed. 39(6). 710–714. 9 indexed citations
13.
Zhang, Chenzi, Wenjun Yu, Lin Wang, et al.. (2017). DNA Methylation Analysis of the SHOX2 and RASSF1A Panel in Bronchoalveolar Lavage Fluid for Lung Cancer Diagnosis. Journal of Cancer. 8(17). 3585–3591. 79 indexed citations
14.
Wang, Lin, Qiaomei Guo, Wenjun Yu, et al.. (2017). Quantification of plasma EGFR mutations in patients with lung cancers: Comparison of the performance of ARMS-Plus and droplet digital PCR. Lung Cancer. 114. 31–37. 18 indexed citations
15.
Wang, Lin, Wenjun Yu, Qiaomei Guo, et al.. (2016). Clinical Significance of Folate Receptor-positive Circulating Tumor Cells Detected by Ligand-targeted Polymerase Chain Reaction in Lung Cancer. Journal of Cancer. 8(1). 104–110. 52 indexed citations
16.
Yu, Wenjun, Yubao Chen, Wenbin Xu, et al.. (2016). Novel phosphatidylinositol 3-kinase inhibitor BKM120 enhances the sensitivity of multiple myeloma to bortezomib and overcomes resistance. Leukemia & lymphoma. 58(2). 428–437. 20 indexed citations
17.
Cao, Yang, Wei Wei, Nan Zhang, et al.. (2015). Oridonin stabilizes retinoic acid receptor alpha through ROS-activated NF-κB signaling. BMC Cancer. 15(1). 248–248. 21 indexed citations
18.
Chen, Xiaoqin, et al.. (2010). Leonurus heterophyllus sweet extract improves hemorheology and inhibits thrombosis in rat with induced myocardial ischemia. Journal of Medicinal Plants Research. 4(9). 732–740. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hengyu Wu Breakdown of academic impact, for papers by Yijie Hao Breakdown of academic impact, for papers by Kenji M. Fujihara Breakdown of academic impact, for papers by Teresa Laguna Breakdown of academic impact, for papers by David T. Hoang Breakdown of academic impact, for papers by Christine Brennan Breakdown of academic impact, for papers by Diane Heiser Breakdown of academic impact, for papers by Li Yuan Breakdown of academic impact, for papers by L. T. Busund Breakdown of academic impact, for papers by Jo Ballot
Rankless by CCL
2026